MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Baxter International Depreciation & Amortization 2011-2026 | BAX
Annual Depreciation & Amortization Baxter International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 981 M | 997 M | 984 M | 1.07 B | 867 M | 823 M | 789 M | 771 M | 750 M | 800 M | 759 M | 792 M | 635 M | 712 M | 670 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.07 B | 635 M | 827 M |
Quarterly Depreciation & Amortization Baxter International
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 237 M | 90 M | 106 M | 247 M | 95 M | 73 M | 271 M | 147 M | 157 M | 313 M | - | 168 M | 193 M | 380 M | - | 645 M | 67 M | 217 M | - | 610 M | 401 M | 199 M | - | 580 M | 385 M | 192 M | - | 586 M | 387 M | 190 M | - | 562 M | 378 M | 194 M | - | 599 M | 395 M | 189 M | - | 593 M | 377 M | 187 M | - | 592 M | 489 M | 236 M | - | 573 M | 366 M | 183 M | - | 534 M | 355 M | 175 M | - | 503 M | 327 M | 158 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 645 M | 67 M | 324 M |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
377 M | $ 68.62 | 2.74 % | $ 13.7 B | USA |
 |
Glaukos Corporation
GKOS
|
38.1 M | $ 126.34 | 3.59 % | $ 7.23 B | USA |
 |
Intuitive Surgical
ISRG
|
600 M | $ 426.61 | 1.91 % | $ 152 B | USA |
 |
ICU Medical
ICUI
|
201 M | $ 142.0 | 3.29 % | $ 3.5 B | USA |
 |
iRhythm Technologies
IRTC
|
20.7 M | $ 113.83 | 6.15 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
810 K | $ 4.0 | 0.25 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
10.4 M | $ 96.59 | 1.56 % | $ 2.19 B | USA |
 |
Masimo Corporation
MASI
|
103 M | $ 179.95 | 0.01 % | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
47 K | $ 1.82 | - | $ 83.3 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
1.57 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
78.2 K | $ 0.39 | 0.29 % | $ 32 M | USA |
 |
Merit Medical Systems
MMSI
|
123 M | $ 67.51 | 2.24 % | $ 3.99 B | USA |
 |
electroCore
ECOR
|
501 K | $ 9.52 | -1.24 % | $ 80.8 K | USA |
 |
Envista Holdings Corporation
NVST
|
116 M | $ 24.59 | 4.91 % | $ 4.13 B | USA |
 |
Haemonetics Corporation
HAE
|
112 M | $ 78.71 | 5.11 % | $ 3.71 B | USA |
 |
STERIS plc
STE
|
486 M | $ 212.88 | 1.1 % | $ 20.9 B | USA |
 |
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
8.32 M | $ 29.87 | -0.3 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
13.3 M | $ 9.01 | - | $ 186 M | USA |
 |
Teleflex Incorporated
TFX
|
178 M | $ 135.75 | 3.04 % | $ 6.06 B | USA |
 |
Utah Medical Products
UTMD
|
826 K | $ 68.07 | 1.52 % | $ 221 M | USA |
 |
West Pharmaceutical Services
WST
|
171 M | $ 334.66 | 4.66 % | $ 24.2 B | USA |
 |
Pulse Biosciences
PLSE
|
406 K | $ 25.77 | 3.74 % | $ 1.74 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
352 M | $ 10.47 | 2.05 % | $ 2.09 B | USA |
 |
Retractable Technologies
RVP
|
7.77 M | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
1.24 M | $ 65.0 | - | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
2.25 M | $ 27.55 | 5.56 % | $ 1.32 B | USA |
 |
Stereotaxis
STXS
|
626 K | $ 1.85 | 2.21 % | $ 168 M | USA |
 |
ResMed
RMD
|
160 M | $ 196.94 | 1.97 % | $ 28.8 B | USA |
 |
AtriCure
ATRC
|
12.1 M | $ 27.3 | 1.43 % | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
1.74 M | $ 6.04 | 0.5 % | $ 268 M | USA |
 |
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
25.8 M | $ 12.34 | 3.44 % | $ 504 M | USA |
 |
Becton, Dickinson and Company
BDX
|
2.46 B | $ 152.04 | 2.08 % | $ 43.7 B | USA |
 |
Nephros
NEPH
|
140 K | $ 3.25 | -4.13 % | $ 34.5 M | USA |
 |
OraSure Technologies
OSUR
|
10.2 M | $ 4.24 | 2.17 % | $ 312 M | USA |
 |
Repligen Corporation
RGEN
|
78.7 M | $ 130.13 | 3.83 % | $ 7.32 M | USA |